Charles River Laboratories Stock Today
| CRL Stock | USD 227.55 2.54 1.10% |
Performance3 of 100
| Odds Of DistressLess than 1
|
Charles River is selling for 227.55 as of the 19th of April 2024. This is a -1.1 percent decrease since the beginning of the trading day. The stock's lowest day price was 223.49. Charles River has a very small chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. Equity ratings for Charles River Laboratories are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 19th of February 2024 and ending today, the 19th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 23rd of June 2000 | Category Healthcare | Classification Health Care |
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. Charles River Laboratories International, Inc. The company has 51.51 M outstanding shares of which 1.58 M shares are currently shorted by investors with about 3.18 days to cover. More on Charles River Laboratories
Moving together with Charles Stock
| 0.87 | A | Agilent Technologies Financial Report 28th of May 2024 | PairCorr |
| 0.87 | EQ | Equillium Financial Report 9th of May 2024 | PairCorr |
Moving against Charles Stock
| 0.75 | KA | Kineta Inc Financial Report 9th of May 2024 | PairCorr |
| 0.66 | VALN | Valneva SE ADR Financial Report 2nd of May 2024 | PairCorr |
| 0.65 | DMTK | DermTech Financial Report 2nd of May 2024 | PairCorr |
| 0.63 | ME | 23Andme Holding | PairCorr |
| 0.62 | VCYT | Veracyte Financial Report 2nd of May 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 9th of May 2024
Charles Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Charles River's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Charles River or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | James Foster | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Name | Comet Resources Ltd | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Life Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NYSE Composite, SP 500 Index, Dow Jones Biotechnology, Health Care, Life Sciences Tools & Services, Diagnostics & Research, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Charles River report their recommendations after researching Charles River's financial statements, talking to executives and customers, or listening in on Charles River's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Charles River Labora. The Charles consensus assessment is calculated by taking the average forecast from all of the analysts covering Charles River. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the analysis of Charles River's profitability, liquidity, and operating efficiency, Charles River Laboratories is performing exceptionally good at this time. It has a great probability to report excellent financial results in May. Financial strength of Charles River Labora is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Charles River's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Charles River's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. Charles River's bond ratings measure its overall creditworthiness, which in many ways corresponds to the cost of borrowing for an issuer. These ratings assign a letter grade to all of Charles River's outstanding corporate bonds that indicate their credit quality. We use reports published by private self-sufficient rating services such as Standard & Poor's or Fitch Ratings Inc. to evaluate a bond issuer's financial strength or its ability to pay a bond's principal and interest. Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Charles River's financial leverage. It provides some insight into what part of Charles River's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Charles River Laboratories (CRL) is traded on New York Stock Exchange in USA. It is located in 251 Ballardvale Street, Wilmington, MA, United States, 01887 and employs 20,400 people. Charles River is listed under Life Sciences Tools & Services category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a total capitalization of 11.97 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Charles River's market, we take the total number of its shares issued and multiply it by Charles River's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Charles River Labora runs under Life Sciences Tools & Services sector within Health Care industry. The entity has 51.51 M outstanding shares of which 1.58 M shares are currently shorted by investors with about 3.18 days to cover.
Charles River Laboratories has about 233.91 M in cash with 683.9 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.96.
Check Charles River Probability Of Bankruptcy
Ownership AllocationCharles River Labora retains a total of 51.51 Million outstanding shares. The majority of Charles River Laboratories outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Charles River Labora to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Charles River. Please pay attention to any change in the institutional holdings of Charles River Laboratories as this could imply that something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Charles Ownership Details
Charles Stock Price Odds Analysis
Proceeding from a normal probability distribution, the odds of Charles River jumping above the current price in 90 days from now is about 77.18%. The Charles River Laboratories probability density function shows the probability of Charles River stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon the stock has a beta coefficient of 2.3306 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Charles River will likely underperform. Additionally, charles River Laboratories has an alpha of 0.0236, implying that it can generate a 0.0236 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Charles River to move above the current price in 90 days from now is about 77.18 (This Charles River Laboratories probability density function shows the probability of Charles Stock to fall within a particular range of prices over 90 days) .
Charles Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Charles River that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Charles River's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Charles River's value.| Instituion | Recorded On | Shares | |
| Amvescap Plc. | 2023-12-31 | 948.3 K | |
| Mackenzie Investments | 2023-12-31 | 917.9 K | |
| Earnest Partners Llc | 2023-12-31 | 889.4 K | |
| Franklin Resources Inc | 2023-12-31 | 763 K | |
| Bank Of America Corp | 2023-12-31 | 736.1 K | |
| Montrusco Bolton Investments Inc | 2023-12-31 | 722.1 K | |
| Fidelity International Ltd | 2023-12-31 | 662.6 K | |
| Sei Investments Co | 2023-12-31 | 568.2 K | |
| Wells Fargo & Co | 2023-12-31 | 545.5 K | |
| Vanguard Group Inc | 2023-12-31 | 6 M | |
| Blackrock Inc | 2023-12-31 | 5.2 M |
Charles River Historical Income Statement
Charles River Laboratories Income Statement is one of the three primary financial statements used for reporting Charles's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Charles River Labora revenue and expense. Charles River Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Charles River's Other Operating Expenses is quite stable compared to the past year. Operating Income is expected to rise to about 648.1 M this year, although the value of Minority Interest is projected to rise to (5.3 M). View More FundamentalsCharles Stock Against Markets
Picking the right benchmark for Charles River stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Charles River stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Charles River is critical whether you are bullish or bearish towards Charles River Laboratories at a given time. Please also check how Charles River's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Charles River without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stock Tickers Now
Stock TickersUse high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
| All Next | Launch Module |
Charles River Corporate Directors
Charles River corporate directors refer to members of a Charles River board of directors. The board of directors generally takes responsibility for the Charles River's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Charles River's board members must vote for the resolution. The Charles River board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Craig Thompson | Director | Profile | |
| Robert Bertolini | Independent Director | Profile | |
| George Milne | Lead Independent Director | Profile | |
| George Llado | Independent Director | Profile |
How to buy Charles Stock?
Before investing in Charles River, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Charles River. To buy Charles River stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Charles River. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Charles River stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Charles River Laboratories stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Charles River Laboratories stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Charles River Laboratories, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Charles Stock please use our How to Invest in Charles River guide.
Already Invested in Charles River Laboratories?
The danger of trading Charles River Laboratories is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Charles River is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Charles River. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Charles River Labora is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Charles River Labora is a strong investment it is important to analyze Charles River's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Charles River's future performance. For an informed investment choice regarding Charles Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Charles River Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for Charles Stock analysis
When running Charles River's price analysis, check to measure Charles River's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Charles River is operating at the current time. Most of Charles River's value examination focuses on studying past and present price action to predict the probability of Charles River's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Charles River's price. Additionally, you may evaluate how the addition of Charles River to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |
Is Charles River's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Charles River. If investors know Charles will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Charles River listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.01) | Earnings Share 9.22 | Revenue Per Share 80.61 | Quarterly Revenue Growth (0.08) | Return On Assets 0.0519 |
The market value of Charles River Labora is measured differently than its book value, which is the value of Charles that is recorded on the company's balance sheet. Investors also form their own opinion of Charles River's value that differs from its market value or its book value, called intrinsic value, which is Charles River's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Charles River's market value can be influenced by many factors that don't directly affect Charles River's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Charles River's value and its price as these two are different measures arrived at by different means. Investors typically determine if Charles River is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Charles River's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.